We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.80 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSPH
RNS Number : 3970G
AIM
06 November 2018
NOTICE
06/11/2018 7:00am
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON
At the request of the Company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.
Hot Features
Premium
SINCLAIR PHARMA PLC
213800BNMD7JVMHW1772
ORDINARY SHARES (3385674) (GB0033856740) SINR PHAR/PAR VTG FPD 0.01
OF 1P EACH, FULLY
PAID
------------------------ --------------------------
If you have any queries or require further information, please contact the company's nominated adviser on +44(0)20 7418 8900.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
AMOMMMGMVKZGRZM
(END) Dow Jones Newswires
November 06, 2018 02:00 ET (07:00 GMT)
1 Year Sinclair Pharma Chart |
1 Month Sinclair Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
